Macrophage inflammatory protein–1α as a costimulatory signal for mast cell–mediated immediate hypersensitivity reactions

D Miyazaki, T Nakamura, M Toda… - The Journal of …, 2005 - Am Soc Clin Investig
D Miyazaki, T Nakamura, M Toda, KW Cheung-Chau, RM Richardson, SJ Ono
The Journal of clinical investigation, 2005Am Soc Clin Investig
Regulation of the immune response requires the cooperation of multiple signals in the
activation of effector cells. For example, T cells require signals emanating from both the TCR
for antigen (upon recognition of MHC/antigenic peptide) and receptors for costimulatory
molecules (eg, CD80 and CD60) for full activation. Here we show that IgE-mediated
reactions in the conjunctiva also require multiple signals. Immediate hypersensitivity
reactions in the conjunctiva were inhibited in mice deficient in macrophage inflammatory …
Regulation of the immune response requires the cooperation of multiple signals in the activation of effector cells. For example, T cells require signals emanating from both the TCR for antigen (upon recognition of MHC/antigenic peptide) and receptors for costimulatory molecules (e.g., CD80 and CD60) for full activation. Here we show that IgE-mediated reactions in the conjunctiva also require multiple signals. Immediate hypersensitivity reactions in the conjunctiva were inhibited in mice deficient in macrophage inflammatory protein–1α (MIP-1α) despite normal numbers of tissue mast cells and no decrease in the levels of allergen-specific IgE. Treatment of sensitized animals with neutralizing antibodies with specificity for MIP-1α also inhibited hypersensitivity in the conjunctiva. In both cases (MIP-1α deficiency and antibody treatment), the degranulation of mast cells in situ was affected. In vitro sensitization assays showed that MIP-1α is indeed required for optimal mast cell degranulation, along with cross-linking of the high-affinity IgE receptor, FcεRI. The data indicate that MIP-1α constitutes an important second signal for mast cell degranulation in the conjunctiva in vivo and consequently for acute-phase disease. Antagonizing the interaction of MIP-1α with its receptor CC chemokine receptor 1 (CCR1) or signal transduction from CCR1 may therefore prove to be effective as an antiinflammatory therapy on the ocular surface.
The Journal of Clinical Investigation